Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4286257
Max Phase: Preclinical
Molecular Formula: C78H102Cl6N10O15S3
Molecular Weight: 1728.65
Molecule Type: Unknown
Associated Items:
ID: ALA4286257
Max Phase: Preclinical
Molecular Formula: C78H102Cl6N10O15S3
Molecular Weight: 1728.65
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CN1Cc2c(Cl)cc(Cl)cc2[C@H](c2ccc(S(=O)(=O)N(C)CCOCCOCCNC(=O)CCN(CCC(=O)NCCOCCOCCN(C)S(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)CCC(=O)NCCOCCOCCN(C)S(=O)(=O)c3cccc([C@@H]4CN(C)Cc5c(Cl)cc(Cl)cc54)c3)cc2)C1
Standard InChI: InChI=1S/C78H102Cl6N10O15S3/c1-88-49-67(64-43-58(79)46-73(82)70(64)52-88)55-13-15-61(16-14-55)110(98,99)91(4)26-32-107-38-35-104-29-20-85-76(95)17-23-94(24-18-77(96)86-21-30-105-36-39-108-33-27-92(5)111(100,101)62-11-7-9-56(41-62)68-50-89(2)53-71-65(68)44-59(80)47-74(71)83)25-19-78(97)87-22-31-106-37-40-109-34-28-93(6)112(102,103)63-12-8-10-57(42-63)69-51-90(3)54-72-66(69)45-60(81)48-75(72)84/h7-16,41-48,67-69H,17-40,49-54H2,1-6H3,(H,85,95)(H,86,96)(H,87,97)/t67-,68-,69-/m0/s1
Standard InChI Key: NHIHNJILORGUAU-AZOUZOSFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1728.65 | Molecular Weight (Monoisotopic): 1724.4819 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. (2016) Nhe3-binding compounds and methods for inhibiting phosphate transport, |
Source(1):